• 1
    Jiang L, Barclay AN. New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1). Eur J Immunol 2009; 39: 116775.
  • 2
    Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, et al. Collagens are functional, high-affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006; 203: 141925.
  • 3
    Tang X, Narayanan S, Peruzzi G, Apara A, Natarajan K, Margulies DH, et al. A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens. J Immunol 2009; 182: 544652.
  • 4
    Omiya R, Tsushima F, Narazaki H, Sakoda Y, Kuramasu A, Kim Y, et al. Leukocyte-associated immunoglobulin-like receptor- 1 is an inhibitory regulator of contact hypersensitivity. Immunology 2009; 128: 54355.
  • 5
    Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH. Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol 1999; 162: 58004.
  • 6
    Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L. p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur J Immunol 1998; 28: 208691.
  • 7
    Saverino D, Fabbi M, Merlo A, Ravera G, Grossi CE, Ciccone E. Surface density expression of the leukocyte-associated Ig-like receptor-1 is directly related to inhibition of human T cell functions. Hum Immunol 2002; 63: 53446.
  • 8
    Van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L. Leukocyte Associated Ig-like Receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling. Eur J Immunol 1999; 29: 31607.
  • 9
    Jansen CA, Cruijsen C, de Ruiter T, Nanlohy N, Willems N, Janssens-Corpela P, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007; 37: 91424.
  • 10
    Verbrugge A, de Ruiter T, Geest C, Coffer PJ, Meyaard L. Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation. J Leukoc Biol 2006; 79: 82836.
  • 11
    Maasho K, Masilamani M, Valas R, Basu S, Coligan JE, Borrego F. The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol Immunol 2005; 42: 152130.
  • 12
    Lebbink RJ, van den Berg MC, de Ruiter T, Raynal N, van Roon JA, Lenting PJ, et al. The soluble LAIR-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction. J Immunol 2008; 180: 16629.
  • 13
    Lenting PJ, Westerlaken GH, Denis CV, Akkerman JW, Meyaard L. Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member. PLoS One 2010; 5: e12174.
  • 14
    Meyaard L. The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 2008; 83: 799803.
  • 15
    Ouyang W, Xue J, Liu J, Jia W, Li Z, Xie X, et al. Establishment of an ELISA system for determining soluble LAIR-1 levels in sera of patients with HFRS and kidney transplant. J Immunol Methods 2004; 292: 10917.
  • 16
    Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997; 7: 28390.
  • 17
    Steevels TA, Lebbink RJ, Westerlaken GH, Coffer PJ, Meyaard L. Signal inhibitory receptor on leukocytes-1 (SIRL-1) is a novel functional inhibitory immune receptor expressed on human phagocytes. J Immunol 2010; 184: 47418.
  • 18
    Founds SA, Fallert-Junecko B, Reinhart TA, Conley YP, Parks WT. LAIR2 localizes specifically to sites of extravillous trophoblast invasion. Placenta 2010; 31: 8805.
  • 19
    Brondijk TH, de Ruiter T, Ballering J, Wienk H, Lebbink RJ, van Ingen H, et al. Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI. Blood 2010; 115: 136473.
  • 20
    Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 295867.
  • 21
    Aletaha D, Funovits J, Breedveld FC, Sharp J, Segurado O, Smolen JS. Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum 2009; 60: 12429.
  • 22
    Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009; 30: 1524.